Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. [electronic resource] by
- Giagounidis, A A N
- Germing, U
- Haase, S
- Hildebrandt, B
- Schlegelberger, B
- Schoch, C
- Wilkens, L
- Heinsch, M
- Willems, H
- Aivado, M
- Aul, C
Producer: 20040210
In:
Leukemia vol. 18
Availability: No items available.
|
|
|
11.
|
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide. [electronic resource] by
- Giagounidis, A A N
- Kulasekararaj, A
- Germing, U
- Radkowski, R
- Haase, S
- Petersen, P
- Göhring, G
- Büsche, G
- Aul, C
- Mufti, G J
- Platzbecker, U
Producer: 20120604
In:
Leukemia vol. 26
Availability: No items available.
|
|
|
12.
|
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). [electronic resource] by
- Germing, U
- Hildebrandt, B
- Pfeilstöcker, M
- Nösslinger, T
- Valent, P
- Fonatsch, C
- Lübbert, M
- Haase, D
- Steidl, C
- Krieger, O
- Stauder, R
- Giagounidis, A A N
- Strupp, C
- Kündgen, A
- Mueller, T
- Haas, R
- Gattermann, N
- Aul, C
Producer: 20060119
In:
Leukemia vol. 19
Availability: No items available.
|